• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
144.46
433619.81
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.89
 

Excel Realty N Infra reports consolidated net loss of Rs 0.26 crore in the December 2025 quarter
Jan 30,2026
Net loss of Excel Realty N Infra reported to Rs 0.26 crore in the quarter ended December 2025 as against net profit of Rs 0.96 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 as against Rs 5.10 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales05.10 -100
OPM %0-6.08 -
PBDT-0.061.01 PL
PBT-0.260.96 PL
NP-0.260.96 PL